RIP assay coupled with PCR confirmed the m6A modification of GLI1/SOX2OT and the direct interaction between GLI1/SOX2OT and METTL3/14 or IGF2BP2 in NSCLC cells (Fig. 4B). The gene discussed is GLI1; the disease is non-small cell lung carcinoma.